This study describes the epidemiology, the clinical features and the course of confirmed chikungunya among a cohort of children. It is a prospective audit of chikungunya cases among children registered for routine medical care at a primary care center. Children presenting with suspected chikungunya were confirmed using real-time reverse transcription polymerase chain reaction. There were 203 suspected cases of chikungunya; of these, 115 samples were tested and 69 (59.0%) were confirmed. The attack rate of chikungunya was 10.2% and 3.5% for the suspected and confirmed cases, respectively. Only six (8.7%) of the children with confirmed chikungunya required hospitalization. Joint pain was a clinical feature in 68 of 69 (98.6%) and skin rash was seen in 32 (46.4%) confirmed cases. The duration of illness was <2 weeks in 89.9% and less than a week in 62.3% of cases. In conclusion, most children had mild clinical manifestations and recovered fully within 2 weeks. K E Y W O R D S : chikungunya, children, clinical features, Caribbean.
Caribbean epidemics [22, 23] . The objectives for this study was to (1) describe the epidemiology of chikungunya among children (<15 years) attending a primary health care center during the first ever Caribbean epidemics, (2) study the clinical features and laboratory findings in the confirmed and unconfirmed cases of chikungunya and (3) describe the course of confirmed cases of chikungunya including short-term complications and long-term sequelae.
M E T H O D S
This is a prospective study of chikungunya cases among children. This study was undertaken at the We Care Medical Center (WCMC), a private medical care facility for children, which is centrally located in the Bridgetown, Barbados. This facility provides continuing primary health care to a cohort of registered children (<15 years of age). From July 2014, children presenting with sudden onset of high fever (T >38.5 C) with limb pain and/or rash had a blood sample drawn for blood counts and laboratory confirmation of chikungunya in addition to the routine screening for dengue, once the parents consented. All these children were interviewed and had a complete physical examination by the attending pediatrician as part of the routine medical care practice, and the findings were recorded.
Children who were seriously ill were referred for admission to the Queen Elizabeth Hospital (QEH). Others were given a follow-up appointment in 7 days for assessment of disease progress and for the fitness certificate to return to day care or school. They were advised to call or return to the facility in case of worsening illness. Children who were referred for admission to the QEH were also followed up 5 days after discharge from the hospital. If they had any residual symptom, then they were seen once again after another week. A further telephonic follow-up was done at 3 months and 6 months after the onset of their illness to record persistence of any residual symptoms or reappearance of any symptom. Blood samples negative for dengue were shipped to the Caribbean Public Health Agency (CARPHA). Samples were tested for the chikungunya virus using real-time reverse transcription polymerase chain reaction technique and reported as positive or negative for the chikungunya virus.
Ethics approval for this study was obtained from the Ethics Board of the University of the West Indies and the Ministry of Health, Barbados. All data were stored in Microsoft Access database. Microsoft excel was used for tabulation, preliminary analysis and generation of graphs. For all proportions, 95% confidence interval with continuity was calculated. Probability was tested for the binominal data by calculation of relative risk with continuity. Chi-square test or Fisher Exact Test were performed for significance and p < 0.05 was considered significant.
R E S U L T S
There were 203 cases of suspected chikungunya from among the 1983 (960 females and 1023 males) children who were registered at the WCMC. Of these 203 suspected cases, parents consented for blood sample in 165 cases, 16 samples were hemolyzed and found to be unsuitable for analysis, 149 were tested for dengue and 27 (18.1%) were positive. Of the remaining 122 samples shipped to CARPHA, 115 samples were tested for chikungunya (7 quantity insufficient) and 69 (59.0%) tested positive. The temporal distribution of the cases of chikungunya is shown in Figure 1 .
The demographics of the chikungunya cases seen at this center is shown in Table 1 . Among the children registered at this medical center, the overall attack rate of chikungunya during this epidemic was 10.2% (95% CI ¼ 9.0%, 11.7%) and 3.5% (95% CI ¼ 2.7%, 4.4%) for the suspected and confirmed cases, respectively. The attack rate for the confirmed cases of chikungunya was higher among the male (3.7%) children compared with the female (3.2%) children (p ¼ 0.639). Table 2 shows selected epidemiological characteristics of confirmed chikungunya in children. In 87.0% of cases, children presented within first 2 days of their illness. The mean duration of onset of symptoms at the time of presentation was 1.9 days (range ¼ 1 day, 5 days) and the median duration was 2 days. Overall, six (8.7%) children (all 5 years) required hospitalization for persistent vomiting: tummy ache in three cases, dehydration in two cases and for bradycardia (Heart Rate [HR] <60 beats per minute) and myocarditis in one case. The mean duration of illness from the time of onset of clinical symptoms to the resolution of symptoms to the point where the child was able to resume day-to-day activity and/or return to school/preschool/day care facility was 6.1 day (Range ¼ 3 days, 18 days) and the median duration of symptoms was 5 days.
The clinical manifestations of Chikungunya in children is shown in Table 3 . The mean recorded temperature among the 69 confirmed cases and the 46 chikungunya negative cases was 39.1 C and 37.9 C, respectively. Difference in the mean temperature in the two groups was 1.19 C (SD ¼ 6 0.3 C) and this difference was significant (p <0.0001). The relative risk of having chikungunya in a child with fever and joint symptom and who had tested negative for dengue was 3.02 (95% CI ¼ 2.0, 4.6) and the difference in the risk was significant (p < 0.0001). All of the 68 children with joint pain had arthralgia, none had any arthritis. Multiple (4) joint involvement was seen in 47 of 68 (69.1%) children. Joint symptoms were part of the initial symptoms in 52 of 68 (76.5%) cases, including 6 where it was the only initial symptom. The relative risk of having chikungunya in febrile children with rash was 1.8 (95% CI ¼ 1.0, 3.1) and the difference in the risk among those who had and those who did not have rash was significant (p ¼ 0.0240). Of the children presenting with rash, 19 children (58.4%) had a maculopapular erythematous, while it was an urticarial rash in 6 (18.7%) cases and polymorphic rash in remaining 7 (21.9%) cases. Itching was associated with 13(40.6%) children presenting with rash. Rash was one of the initial presentations in nine cases. Fever with arthralgia and rash was seen in 32 (46.4%) positive and 3 (6.5%) negative cases (Respiratory Rate [RR] ¼ 7.1; 95% CI ¼ 2.3, 21.9).
Eleven (15.9%) children had vomiting, 7 (10.1%) had tummy ache and 3 (4.3%) had loose stool. Body ache or myalgia was reported in 8 (11.6%). Myocarditis was diagnosed in one child who required hospitalization for persistent bradycardia, high fever and poor oral intake. Myocarditis was also detected in one other child who was initially found to be positive for dengue and had to be admitted for low platelets count. He also had persistent bradycardia and hypotension. He had a second sample sent on day 6 of his illness that tested positive for chikungunya. In both these cases, Electrocardiography (ECG), cardiac enzymes and Echocardiography (ECHO) study were suggestive of myocarditis.
Two children (2.9%; 95% CI ¼ 0.5%, 11.1%) with confirmed chikungunya, aged 8 and 13 years, had a recurrence of occasional mild pain in joints on follow-up at 3 months and 6 months, respectively. Only one of these children sought medical attention. We did not observe any serious complications other than the myocarditis in this cohort. There was no mortality.
D I S C U S S I O N S
There is a need for more studies of chikungunya in children [24, 25] , especially those from the western hemisphere where it is an emerging disease [26] . First few cases of chikungunya were reported from Barbados in July 2014 [27] [28] [29] and prompted surveillance and testing for chikungunya. This epidemic occurred against the background of a pan-Caribbean chikungunya epidemic [15, 16, 27, 28] . The first chikungunya epidemic in this population was characterized by a steep increase in the number of cases during the first 2 months and then a steep decrease in number of cases. A similar pattern has been reported from several countries of south-east Asia as well as those in the neighboring Caribbean islands during their first epidemics of chikungunya [16, 26, [30] [31] [32] [33] . The epidemic months of chikungunya coincided with the months of the most rainfall and with those of the peak season for the dengue infection in this country [22, 23] . The overall attack rate of the suspected and confirmed cases of chikungunya in this cohort of children was 10.2 and 3.5%, respectively. A similar attack rate of confirmed chikungunya was seen in a prospective study of a cohort of children (2-14 years) with chikungunya from Nicaragua in Central America reporting an overall rate of 2.9% [26] . Attack rates of chikungunya have been variously reported from different geographic area [16, [30] [31] [32] [33] [34] [35] [36] [37] . We observed an increased attack rate with increasing age where the highest incidence rate was seen among children in the age group 10 to <15 years. Similar findings have been reported in some other studies of children that are published [25, 26, 38, 39] .
Chikungunya in this cohort had a hyper-acute onset of symptoms necessitating early presentation for care. Similar observations have been made in a population-based prospective study form Congo [40] . High fever seen in this cohort has also been reported in other studies [41, 42] . The risk ratio for chikungunya among children who had fever and arthralgia was 3.02. Frequency of occurrence of arthralgia and arthritis among children with chikungunya has been variously reported [25, 38] . In over four-fifths of cases, arthralgia was one of the symptoms at the time of presentation. Rash was seen in nearly half of our cases and it has been reported to occur in 30 to 60% of cases in other studies [25, 38] . Children with high fever with arthralgia and rash had a high risk of chikungunya (RR ¼ 7.1). Myocarditis has been reported as possible emerging among adults with chikungunya in the Americas [43] . Of note we had one case of myocarditis among children who tested positive for chikungunya and an additional case who tested positive for both chikungunya and dengue. Only 10% of the children with confirmed chikungunya had symptoms beyond 2 weeks. Studies from the South-East Asia and Africa that included both the children and adults have reported longer duration of chikungunya with higher proportion of affected persons having long-term joint symptoms [35, 39] . Less than 5% of children with confirmed chikungunya had a long-term chronic problem with joint pain. Overall, the severity of chikungunya in this cohort was milder than those reported in other studies [25, 30, [33] [34] [35] [36] [37] [38] [39] . The milder form of chikungunya seen in this cohort resulted either from early presentation owing to easy access to health care or owing to the strain of chikungunya causing this epidemic. It is unlikely that early presentation could have altered the course of the illness, as most cases had limited intervention limited to prescription of analgesics combination of Acetaminophen and Codeine if necessary. More likely, the findings from this study supports the conclusion from another recent study that the symptoms of patients with AsianCaribbean Chikungunya virus (CHIKV) might be somewhat milder to those with the East/Central/ South African (ECSA) strain [44] .
The major strength of this study is the prospective study design in a cohort of children at a single medical center with a high (nearly 90%) retention rate. A major limitation of this study was that only children with fever and arthralgia and/or rash were tested for chikungunya. As a result, we may have missed the chikungunya in children with undifferentiated fever. Also, only 56.6% of all suspected chikungunya had a confirmatory test.
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